<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Cachexia &#8211; Beirne B. Carter Center for Immunology Research</title>
	<atom:link href="https://www.immunology.virginia.edu/tag/cachexia/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.immunology.virginia.edu</link>
	<description>World-Class Research</description>
	<lastBuildDate>Wed, 25 Feb 2026 19:19:55 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://www.immunology.virginia.edu/wp-content/uploads/2021/10/cic_logo_v3_small_web-1-100x100.png</url>
	<title>Cachexia &#8211; Beirne B. Carter Center for Immunology Research</title>
	<link>https://www.immunology.virginia.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">207838024</site>	<item>
		<title>Sarah Ewald, PhD, receives NIH-R35 Award to Study Cachexia</title>
		<link>https://www.immunology.virginia.edu/sarah-ewald-phd-receives-nih-r35-award-to-study-cachexia/</link>
		
		<dc:creator><![CDATA[Chris Baryiames]]></dc:creator>
		<pubDate>Thu, 25 Sep 2025 13:50:17 +0000</pubDate>
				<category><![CDATA[News]]></category>
		<category><![CDATA[Cachexia]]></category>
		<category><![CDATA[Ewald Lab]]></category>
		<category><![CDATA[Grant Award]]></category>
		<guid isPermaLink="false">https://www.immunology.virginia.edu/?p=6499</guid>

					<description><![CDATA[Sarah Ewald, PhD, CIC resident member and Associate Professor of Microbiology, Immunology, and Cancer Biology, was awarded a five-year, $2.35 million R35 grant from the NIH. These funds will allow the Ewald Lab to further study the role of the &#8230; <a class="kt-excerpt-readmore more-link" href="https://www.immunology.virginia.edu/sarah-ewald-phd-receives-nih-r35-award-to-study-cachexia/">Read More</a>]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph">Sarah Ewald, PhD, CIC resident member and Associate Professor of Microbiology, Immunology, and Cancer Biology, was awarded a five-year, $2.35 million R35 grant from the NIH. These funds will allow the Ewald Lab to further study the role of the gut microbiome in cachexia, a chronic wasting disease. The award has been featured in this week&#8217;s <a href="https://news.med.virginia.edu/research/sarah-ewald-phd-earns-five-year-2-3-million-nih-r35-award-to-study-innate-inflammatory-control-of-cachexia/"><em>Medicine in Motion.</em></a></p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">6499</post-id>	</item>
	</channel>
</rss>
